AbbVie · 23 hours ago
2026 Business Technology Solutions Intern - Software Engineer
AbbVie is a pharmaceutical company dedicated to discovering and delivering innovative medicines and solutions. The Software Engineer Intern will work in a collaborative Agile environment to design and enhance applications, gaining valuable experience while contributing to impactful projects.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Design, build, and enhance applications used by AbbVie employees and customers
Work collaboratively, as part of an Agile team, with Business Analysts, Scrum Masters, Product Managers, and various business owners
Experiment and learn new skills while working on innovative stretch assignments
Qualification
Required
Currently enrolled in university, pursuing a bachelors degree in Engineering (Computer, Industrial, or related fields, or Computer Science or other related field
Must be enrolled in university for at least one semester following the internship
Expected graduation date between December 2026 – June 2027
Technology Skills: Programming Language: Python, or Java
Preferred
Exposure to database, coding, infrastructure, etc
Java, JavaScript, TypeScript, NodeJS, Vue.js, and HTML
Benefits
Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Recent News
2026-01-09
2026-01-09
Company data provided by crunchbase